ValenTx's Series B Round

ValenTx raised a round of funding on September 14, 2009.

ValenTx is developing a new therapy to treat patients with obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension. The company's technology mimics the therapeutic mec…

Articles about ValenTx's Series B Round: